[Diabetes mellitus, hyperlipemia, fatty liver, hypertension in primary gout and their influencing by benzbromaronum].
D000328:Adult; D001572:Benzofurans / Q000009:adverse effects / Q000627:therapeutic use*; D001786:Blood Glucose / Q000032:analysis; D001799:Blood Sedimentation; D003078:Colchicine / Q000627:therapeutic use; D003404:Creatinine / Q000097:blood; D003920:Diabetes Mellitus / Q000188:drug therapy*; D004562:Electrocardiography; D005234:Fatty Liver / Q000150:complications / Q000188:drug therapy*; D005260:Female; D006073:Gout / Q000097:blood / Q000150:complications / Q000188:drug therapy* / Q000517:prevention & control; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications / Q000188:drug therapy*; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D008055:Lipids / Q000097:blood; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D014527:Uric Acid / Q000097:blood
D001572:Benzofurans; D001786:Blood Glucose; D008055:Lipids; D014527:Uric Acid; D003404:Creatinine; D003078:Colchicine
Diabetes mellitus Hyperlipidämie, Fettleber, Hypertension bei primärer Gicht und deren Beeinflussung durch Benzobromaronum.